Results and prognostic factors in stage IE-IIE primary gastric lymphoma after gastrectomy

被引:10
|
作者
Rodríguez-Sanjuán, JC
Alvarez-Cañas, C
Casado, F
García-Castrillo, L
Casanova, D
Val-Bernal, F
Naranjo, A
机构
[1] Univ Hosp Marques de Valdecilla, Dept Gen Surg, Santander, Spain
[2] Univ Hosp Marques de Valdecilla, Dept Pathol, Santander, Spain
关键词
D O I
10.1016/S1072-7515(98)00302-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Infrequency of gastric lymphomas and lack of homogeneity of studies dealing with them preclude accurate management schemes. Helicobacter pylori (HP) and Isaacson's classification are new factors to consider. Our aim was to analyze these and other prognostic factors in a homogeneous series. Study Design: Fifty-four patients (mean age 62.4 years) treated by gastrectomy for primary gastric non-Hodgkin's lymphoma in stages I-E or IIE were retrospectively reviewed. Twenty-seven patients received postoperative chemotherapy. HP and histologic features were studied using new slides from the paraffin-embedded gastrectomy specimens. Results: Postoperative morbidity and mortality rates were 19% and 5.6%, respectively. Five-year survival was 83%. Classification showed low-grade tumors in 59% and high-grade tumors in 41%. HP was positive in 64% of the patients. A poorer survival was associated with high-grade tumors (p = 0.02) and serosa involvement (p = 0.02). We did not find any significant difference between patients treated either by partial or total gastrectomy (p = 0.2), or receiving chemotherapy or not (p = 0.9). Nor did we appreciate any differences concerning margin involvement (p = 0.9). Conclusions: Most primary gastric lymphoma patients have gastric HP. Serosa involvement and high-grade tumors adversely influence survival but gastrectomy type, resection margin invasion, and postoperative chemotherapy did not appear to have any influence. (J Am Coil Surg 1999;188:296-303. (C) 1999 by the American College of Surgeons).
引用
收藏
页码:296 / 303
页数:8
相关论文
共 50 条
  • [31] Stage IE primary nonHodgkin's lymphoma of bone
    Marshall, DT
    Amdur, RJ
    Scarborough, MT
    Mendenhall, NP
    Virkus, WW
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2002, (405) : 216 - 222
  • [32] Stage IE and IIE extranodal non-hodgkin lymphomas: Results of treatment with radiotherapy
    Lessard, N.
    Vallires, I.
    Fortin, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S34 - S34
  • [33] Stage IE and IIE extranodal non-Hogdkin lymphomas:: Results of treatment with radiotherapy
    Lessard, N.
    Vallières, I.
    Fortin, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S507 - S508
  • [34] Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission
    Li, Qiwen
    Li, Wei
    Wang, Liang
    Wang, Weida
    Niu, Shaoqing
    Bi, Xiwen
    Wang, Hanyu
    Zhang, Yujing
    PLOS ONE, 2015, 10 (07):
  • [35] Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE
    Raderer, M
    Valencak, J
    Österreicher, C
    Drach, J
    Hejna, M
    Kornek, G
    Scheithauer, W
    Brodowicz, T
    Chott, A
    Dragosics, B
    CANCER, 2000, 88 (09) : 1979 - 1985
  • [36] ADJUVANT CHEMOTHERAPY FOR STAGE IE AND IIE GASTROINTESTINAL NON-HODGKINS-LYMPHOMA (GI-NHL)
    YAU, JC
    SHEPHERD, FA
    EVANS, WK
    SCOTT, JG
    FRANCOMBE, WH
    BAKER, MA
    REYNOSO, E
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1986, 9 (03): : A79 - A79
  • [37] Surgical management of stage IE/IIE primary pulmonary lymphomas: a propensity score matching study
    Cao, Jie
    Lin, Huahang
    Peng, Zhiyu
    Huang, Zhaokang
    Liu, Zetao
    Guo, Chenglin
    Mei, Jiandong
    JOURNAL OF THORACIC DISEASE, 2025, 17 (01)
  • [39] The prognostic potential of pretreatment C-reactive protein to albumin ratio in stage IE/IIE extranodal natural killer/T-cell lymphoma
    Xiaoying Quan
    Chunzhi Wu
    Lei Lei
    Xiaoyan Chen
    Bin Ye
    OncologyandTranslationalMedicine, 2019, 5 (04) : 162 - 169
  • [40] Intensity-modulated radiotherapy has superior outcomes to three-dimensional conformal radiotherapy in patients with stage IE-IIE extranodal nasal-type natural killer/T-cell lymphoma
    Li, Yi-Yang
    Lin, Hai-Qun
    Zhang, Lu-Lu
    Feng, Ling-Ling
    Niu, Shao-Qing
    Wang, Han-Yu
    Zhang, Yu-Jing
    Wang, Xi-Cheng
    ONCOTARGET, 2017, 8 (36) : 60504 - 60513